cyclosporine and Cancer of the Uterus

cyclosporine has been researched along with Cancer of the Uterus in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atkinson, DE; Fairbairn, LJ; Glazier, JD; Greenwood, SL; Sibley, CP1
Anderson, B; Buller, RE; Skilling, JS; Sood, AK; Sorosky, JI; Squatrito, RC1
Beijnen, JH; Duchin, K; Koopman, FJ; Lieverst, J; Malingré, MM; Rosing, H; Schellens, JH; Swart, M; ten Bokkel Huinink, WW; van Tellingen, O1
Ganapathy, V; Leibach, FH; Mahesh, VB; Ramamoorthy, S1

Trials

1 trial(s) available for cyclosporine and Cancer of the Uterus

ArticleYear
The effect of different doses of cyclosporin A on the systemic exposure of orally administered paclitaxel.
    Anti-cancer drugs, 2001, Volume: 12, Issue:4

    Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Carcinoma, Small Cell; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasms; Paclitaxel; Premedication; Stomach Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms

2001

Other Studies

3 other study(ies) available for cyclosporine and Cancer of the Uterus

ArticleYear
Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer.
    American journal of physiology. Cell physiology, 2003, Volume: 285, Issue:3

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Choriocarcinoma; Female; Gene Expression; Gene Transfer Techniques; Humans; Immunohistochemistry; Multidrug Resistance-Associated Proteins; Pregnancy; Retroviridae; RNA, Messenger; Transduction, Genetic; Trophoblasts; Tumor Cells, Cultured; Uterine Neoplasms

2003
Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies.
    Neoplasia (New York, N.Y.), 1999, Volume: 1, Issue:2

    Topics: Choriocarcinoma; Cyclosporine; Disease Progression; Drug Resistance, Multiple; Female; Genital Neoplasms, Female; Humans; Immunosuppressive Agents; Middle Aged; Ovarian Neoplasms; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms; Uterine Neoplasms

1999
Selective impairment of taurine transport by cyclosporin A in a human placental cell line.
    Pediatric research, 1992, Volume: 32, Issue:1

    Topics: Biological Transport, Active; Cell Line; Choriocarcinoma; Cyclosporine; Female; Humans; Placenta; Pregnancy; Tacrolimus; Taurine; Tumor Cells, Cultured; Uterine Neoplasms

1992